Prestige BioPharma Limited (KOSE: A950210)
Health Care · Biotechnology · SG
₩5,690.00
-4.53% today · -53.6% 1Y
Prestige BioPharma Limited (KOSE: A950210) operates in the Biotechnology industry within the Health Care sector. The company is valued at $51.30M.
Over the last twelve months the share price has lost 53.6%, trading between 4.95K and 14.12K.
Tweenvest scores Prestige BioPharma Limited across four factors: quality 38/100, value 69/100. Its strongest factor is value.
A950210 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $51.30M
- Revenue (TTM)
- $16.84M
- P/E
- —
- EPS
- -1,522.60
- Dividend yield
- —
- Beta (5Y)
- 0.35
- 52-week high
- ₩14,120.00
- 52-week low
- ₩4,945.00
- Avg volume (3M)
- —
- Shares outstanding
- 12.02M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| CG Invites Co., Ltd.KOSDAQ: A083790 | $52.02M | ₩902.00 | -3.01% |
| CellSeed Inc.TSE: 7776 | $51.50M | ¥206.00 | -2.37% |
| RenovoRx, Inc.NasdaqCM: RNXT | $51.45M | $1.14 | -10.94% |
| Synbio Tech Inc.TPEX: 1295 | $51.37M | NT$48.35 | -3.49% |
| Nano Holdings, Inc.TSE: 4571 | $51.13M | ¥89.00 | +12.66% |
| Uni-Bio Science Group LimitedSEHK: 690 | $50.98M | HK$0.07 | -4.29% |
| Rein Therapeutics Inc.NasdaqCM: RNTX | $50.92M | $0.59 | -25.65% |
| Cellid, Co., Ltd.KOSDAQ: A299660 | $50.90M | ₩2,300.00 | -8.18% |
Figures last refreshed Oct 18, 2026.